A Phase 1, Multiple-Dose, Open-Label Study To Evaluate The Safety,Tolerability, And Pharmacokinetics Of Olz/Sam In Pediatric Subjects (10-12 Years Old) With Bipolar I Disorder
Posted Date: Jun 15, 2021
- Investigator: Melissa Delbello
- Specialties: Bipolar Disorder, Psychiatry/Psychology
- Type of Study: Drug
A study to evaluate the safety, tolerability, and pharmacokinetics of the study drug in pediatric subjects (10 to 12 years old) with bipolar I disorder.
Criteria:
10-12 Year Old With Bipolar I Disorder
Keywords:
Bipolar I Disorder, Pk, Pediatric
For More Information:
Raechel Cooley, B.A
513-558-6205
cooleyra@ucmail.uc.edu